Acquisition and maintenance of DNA methylation in genomic imprinting

描述（由申请人提供）：基因组印记对哺乳动物的发育至关重要。印迹基因的失调可导致癌症、糖尿病、心血管疾病和其他各种人类疾病。尽管基因组印记在哺乳动物中被发现已近30年，但目前尚不清楚基因组印记是否在晚期胚胎发育中起作用。关于基因组印记记忆的本质以及基因组印记是如何建立和维持的，仍然存在许多悬而未决的问题。本研究旨在揭示小鼠胚胎和细胞培养中DNA甲基化印迹的建立、维持和获得的潜在分子机制。这些目标现在可以实现，因为我们已经发现了DNA甲基化印记中的一个重要调节因子。我们的初步结果表明，ZFP57似乎是心血管发育所必需的。ZFP57可以将DNA甲基转移酶靶向到印迹控制区，以启动和维持DNA甲基化印迹。我们提出的实验将研究ZFP57是否通过其靶印迹基因调控心血管发育中的LIN-12/Notch信号，从而将基因组印迹与胚胎发育晚期联系起来。本研究的预期结果将进一步加深我们对DNA甲基化印记的建立和维持的理解，为未来研究揭示基因组印记记忆的分子本质奠定基础。这些实验的成功完成也将为多能干细胞中DNA甲基化印记的操作提供原理证明，用于未来的治疗应用。

DESCRIPTION (provided by applicant): Genomic imprinting is essential for mammalian development. Dysregulation of imprinting genes can lead to cancer, diabetes, cardiovascular diseases and other kinds of human diseases. Although genomic imprinting was identified in mammals almost three decades ago, it is still unclear if genomic imprinting plays a role in late embryonic development. Many unanswered questions persist about the nature of genomic imprinting memory and about how genomic imprints are established and maintained. This proposal aims to uncover the underlying molecular mechanisms of establishment, maintenance and acquisition of DNA methylation imprints in mouse embryos and in cell culture. These objectives can be reached now because we have discovered an important regulator in DNA methylation imprints. Our preliminary results indicate that ZFP57 appears to be required for cardiovascular development. ZFP57 can target DNA methyltransferases to imprinting control regions to initiate and maintain DNA methylation imprints. Our proposed experiments will examine whether ZFP57 regulates LIN-12/Notch signaling in cardiovascular development via its target imprinted gene, thereby linking genomic imprinting to late stages of embryonic development. The expected outcome from this research will further our understanding of the establishment and maintenance of DNA methylation imprints, setting the stage for future studies to unravel the molecular nature of genomic imprinting memory. Successful completion of these experiments will also provide proof of principle for manipulating DNA methylation imprints in pluripotent stem cells for future therapeutic applications. PUBLIC HEALTH RELEVANCE: Dysregulation of genomic imprinting are associated with a variety of human diseases including metabolic diseases, cardiovascular diseases and cancer. Indeed, it was just published that mutations in human Zfp57 result in hypomethylation at multiple imprinted regions and are associated with transient neonatal diabetes and congenital heart defects.